Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Cancer Drug Retail Prices Vastly Different Between Countries
A pilot study revealed large differences in median retail prices for 23 cancer drugs in seven different countries, with the highest retail prices identified in the United States and the lowest in Indi...
State announces grants to lure smaller biotechs
SAN FRANCISCO — When senior Massachusetts officials sat out last year’s Biotechnology Innovation Organization convention, life sciences executives wondered whether the new Baker administration wou...
The First DNA Sequencing in Space Could Happen This Summer
When Kate Rubins heard back from NASA in 2009, she traded her clean suit for a spacesuit.
Shire completes combination with Baxalta creating the global leader in rare diseases and highly specialized conditions
Dublin, Ireland – June 3, 2016 – Shire plc (LSE.
Why forgetting may be good for memory
For managing the memories acquired across a lifetime, human beings need to forget -- as part of the brains' system, says new research that has identified a new protein required for normal forgetti...
Diabetes Drug May Help Some Patients Beat Breast Cancer
New York.
AstraZeneca sells EU, Latam gout drug rights to Gruenenthal
AstraZeneca has sold the European and Latin American rights to its new gout drug Zurampic to private German drugmaker Gruenenthal for up to $230 million, following a similar disposal of U.
FDA approves Zinbryta to treat relapsing forms of multiple sclerosis
Biogen and AbbVie have secured approval from the US Food and Drug Administration for Zinbryta (daclizumab) to treat adults with relapsing forms of multiple sclerosis (MS).
Botswana gets GSK's modern HIV drug in largest ever Africa deal
An HIV drug first approved less than three years ago is being rolled out in Botswana as a core medicine for newly diagnosed patients, following the largest ever tender secured by GlaxoSmithKline's...
FDA Advisory Committee Recommends Approval for Sanofi's Type 2 Diabetes Drug
Sanofi announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.
U.S. FDA Approves Once-daily Jentadueto® XR (linagliptin and metformin hydrochloride extended-release) Tablets for Adults with Type 2 Diabetes
RIDGEFIELD, Conn.
Jazz Pharma to buy Celator in $1.5 billion deal
Ireland-based Jazz Pharmaceuticals Plc will buy U.
620
621
622
623
624
625
626
627
628
